700 results on '"Pijnenburg, Yolande A. L."'
Search Results
2. The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
3. Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles
4. Longitudinal changes in qualitative aspects of semantic fluency in presymptomatic and prodromal genetic frontotemporal dementia
5. TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration
6. Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population
7. Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex
8. Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
9. Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration
10. Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
11. Discovery of novel CSF biomarkers to predict progression in dementia using machine learning
12. The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer’s disease: a natural language processing study
13. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
14. Severe CTE and TDP-43 pathology in a former professional soccer player with dementia: a clinicopathological case report and review of the literature
15. Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders
16. CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
17. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
18. New insights into the genetic etiology of Alzheimer’s disease and related dementias
19. The natural history of primary progressive aphasia: beyond aphasia
20. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study
21. Rationale and design of the “NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)” study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy
22. Cognitive composites for genetic frontotemporal dementia: GENFI-Cog
23. Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia
24. Mapping the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families
25. YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer’s disease and frontotemporal lobar degeneration
26. Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.
27. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice.
28. The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials
29. Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia
30. Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen
31. Social cognition differentiates phenocopy syndrome of behavioural variant frontotemporal dementia from behavioural variant frontotemporal dementia.
32. Rapidly progressive dementias — leukodystrophies as a potentially treatable cause
33. Musical experience influences socio-emotional functioning in behavioural variant frontotemporal dementia
34. Cognitively Healthy Centenarians are genetically protected against Alzheimer’s disease
35. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
36. Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansions
37. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
38. A Computational Network Model for the Effects of Certain Types of Dementia on Social Functioning
39. Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.
40. Sociale cognitie bij frontotemporale dementie
41. Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta‐analysis of empirical data
42. Young‐onset dementia in memory clinics in the Netherlands: Study design and description of PRECODE‐GP
43. CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease
44. Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease
45. Musical experience influences socio-emotional functioning in behavioural variant frontotemporal dementia.
46. Impact of COVID‐19 pandemic on mortality rate in memory clinic patients.
47. The ScreeLing: Detecting Semantic, Phonological, and Syntactic Deficits in the Clinical Subtypes of Frontotemporal and Alzheimer's Dementia.
48. The Effect of Predictive Testing in Adult-Onset Neurodegenerative Diseases on Social and Personal Life
49. Decreased emotion recognition and reduced focus on facial hallmarks in behavioral variant frontotemporal dementia compared to primary psychiatric disorders and controls
50. What does heritability of Alzheimer’s disease represent?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.